Vesugen for Longevity
Khavinson tripeptide (Lys-Glu-Asp) marketed as a vascular bioregulator.
Why Vesugen for longevity?
Vesugen is a Lys-Glu-Asp tripeptide from the Khavinson short-peptide series, positioned as a 'vasoprotective bioregulator'. Russian publications report effects on endothelial function and lipid markers in aged animals. Independent peer-reviewed replication is limited; mechanism claims of selective gene expression remain controversial.
Longevity context: Targeting senescent cells, mitochondrial function, telomere maintenance, and cellular resilience. Vesugen fits this goal because its category (Longevity) and benefit profile align with the underlying mechanism.
Benefits relevant to longevity
- Claimed endothelial support
- Studied in atherosclerosis (Russia)
Reference dosing by bodyweight
Anchored to the most-cited research dose (100 mcg @ 75 kg). Reference only.
| Bodyweight band | Reference dose range |
|---|---|
| <60 kg / <132 lb | 62–84 mcg |
| 60–75 kg / 132–165 lb | 77–103 mcg |
| 75–90 kg / 165–198 lb | 94–126 mcg |
| 90–105 kg / 198–231 lb | 111–150 mcg |
| >105 kg / >231 lb | 128–173 mcg |
Side effects to weigh against longevity benefit
- Limited Western safety data
Also researched for
Educational use only
This calculator is provided for research and educational purposes. Outputs are derived from the values you enter. Always verify your math and consult a licensed physician before acting on any result.